{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:31:31Z","timestamp":1790022691231,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14742-4","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:19:37Z","timestamp":1754414377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel prediction nomogram model for recurrent\/persistent disease versus the American thyroid association recurrence risk stratification in patients with N1b papillary thyroid cancer: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Jin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuansheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xigang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9488-6460","authenticated-orcid":false,"given":"Feng","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0437-3616","authenticated-orcid":false,"given":"Xudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"14742_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMra1501993","volume":"375","author":"JA Fagin","year":"2016","unstructured":"Fagin JA, Wells SA. Biologic and clinical perspectives on thyroid cancer. N Engl J Med. 2016;375:1054\u201367.","journal-title":"N Engl J Med"},{"key":"14742_CR2","first-page":"409","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72:409\u201336.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"14742_CR3","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.6004\/jnccn.2018.0089","volume":"16","author":"RI Haddad","year":"2018","unstructured":"Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh Q-Y, Ehya H, Goldner W, et al. NCCN guidelines insights: thyroid carcinoma, version 2.2018. J Natl Compr Canc Netw. 2018;16(12):1429\u201340.","journal-title":"J Natl Compr Canc Netw"},{"key":"14742_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1101410","volume":"14","author":"J Patel","year":"2023","unstructured":"Patel J, Klopper J, Cottrill EE. Molecular diagnostics in the evaluation of thyroid nodules: current use and prospective opportunities. Front Endocrinol (Lausanne). 2023;14: 1101410.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"14742_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11061043","author":"V Fiorentino","year":"2021","unstructured":"Fiorentino V, Dell\u2019 Aquila M, Musarra T, Martini M, Capodimonti S, Fadda G, Curatolo M, Traini E, Raffaelli M, Lombardi CP, et al. The role of cytology in the diagnosis of subcentimeter thyroid lesions. Diagnostics. 2021. https:\/\/doi.org\/10.3390\/diagnostics11061043.","journal-title":"Diagnostics"},{"key":"14742_CR6","doi-asserted-by":"publisher","unstructured":"Lebbink CA, Links TP, Czarniecka A, Dias RP, Elisei R, Izatt L, Krude H, Lorenz K, Luster M, Newbold K et al. 2022 European thyroid association guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J. 2022;11(6):e220146. https:\/\/doi.org\/10.1530\/ETJ-22-0146.","DOI":"10.1530\/ETJ-22-0146"},{"issue":"11","key":"14742_CR7","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1210\/jc.2019-00962","volume":"104","author":"G Grani","year":"2019","unstructured":"Grani G, Ramundo V, Falcone R, Lamartina L, Montesano T, Biffoni M, Giacomelli L, Sponziello M, Verrienti A, Schlumberger M, et al. Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound. J Clin Endocrinol Metab. 2019;104(11):4981\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"14742_CR8","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1055-9965.EPI-21-1440","volume":"31","author":"CM Kitahara","year":"2022","unstructured":"Kitahara CM, Schneider AB. Epidemiology of thyroid cancer. Cancer Epidemiol Biomarkers Prev. 2022;31(7):1284\u201397.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"14742_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/01.SLA.0000055273.58908.19","volume":"237","author":"N Wada","year":"2003","unstructured":"Wada N, Duh Q-Y, Sugino K, Iwasaki H, Kameyama K, Mimura T, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399\u2013407.","journal-title":"Ann Surg"},{"key":"14742_CR10","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1089\/thy.2012.0043","volume":"22","author":"GW Randolph","year":"2012","unstructured":"Randolph GW, Duh Q-Y, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid. 2012;22:1144\u201352.","journal-title":"Thyroid"},{"issue":"1","key":"14742_CR11","first-page":"26","volume":"2016","author":"BR Haugen","year":"2015","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid Off J Am Thyroid Assoc. 2015;2016(1):26.","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"14742_CR12","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1089\/thy.2013.0027","volume":"23","author":"M Lango","year":"2013","unstructured":"Lango M, Flieder D, Arrangoiz R, Veloski C, Yu JQ, Li T, et al. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. Thyroid. 2013;23:1099\u2013105.","journal-title":"Thyroid"},{"key":"14742_CR13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1097\/JS9.0000000000000316","volume":"109","author":"S-T Yu","year":"2023","unstructured":"Yu S-T, Ge J, Wei Z, Sun B, Xiao Z, Li T, et al. The lymph node yield in the initial lateral neck dissection predicts recurrence in the lateral neck of papillary thyroid carcinoma: a revision surgery cohort study. Int J Surg. 2023;109:1264\u201370.","journal-title":"Int J Surg"},{"key":"14742_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1\u201322.","journal-title":"J Stat Softw"},{"key":"14742_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak. 2006;26:565\u201374.","journal-title":"Med Decis Mak"},{"key":"14742_CR16","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.surg.2013.06.043","volume":"154","author":"S Young","year":"2013","unstructured":"Young S, Harari A, Smooke-Praw S, Ituarte PHG, Yeh MW. Effect of reoperation on outcomes in papillary thyroid cancer. Surgery. 2013;154:1354\u201361. discussion 1361.","journal-title":"Surgery"},{"key":"14742_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/thy.2017.0422","volume":"28","author":"L Jianyong","year":"2018","unstructured":"Jianyong L, Jinjing Z, Zhihui L, Tao W, Rixiang G, Jingqiang Z. A nomogram based on the characteristics of metastatic lymph nodes to predict papillary thyroid carcinoma recurrence. Thyroid. 2018;28:301\u201310.","journal-title":"Thyroid"},{"key":"14742_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5455\/medarh.2018.72.108-111","volume":"72","author":"S Maksimovic","year":"2018","unstructured":"Maksimovic S, Jakovljevic B, Gojkovic Z. Lymph node metastases papillary thyroid carcinoma and their importance in recurrence of disease. Med Arch. 2018;72:108\u201311.","journal-title":"Med Arch"},{"key":"14742_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1634\/theoncologist.2012-0240","volume":"18","author":"DF Schneider","year":"2013","unstructured":"Schneider DF, Mazeh H, Chen H, Sippel RS. Lymph node ratio predicts recurrence in papillary thyroid cancer. Oncologist. 2013;18:157\u201362.","journal-title":"Oncologist"},{"key":"14742_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/hed.23047","volume":"35","author":"J Yip","year":"2013","unstructured":"Yip J, Orlov S, Orlov D, Vaisman A, Hern\u00e1ndez KG, Etarsky D, et al. Predictive value of metastatic cervical lymph node ratio in papillary thyroid carcinoma recurrence. Head Neck. 2013;35:592\u20138.","journal-title":"Head Neck"},{"key":"14742_CR21","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1210\/jc.2005-0285","volume":"90","author":"S Leboulleux","year":"2005","unstructured":"Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart J-M, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and\/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005;90:5723\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"14742_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0039-6060(03)00384-2","volume":"135","author":"I Sugitani","year":"2004","unstructured":"Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery. 2004;135:139\u201348.","journal-title":"Surgery"},{"key":"14742_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.suronc.2008.04.005","volume":"17","author":"IM Cranshaw","year":"2008","unstructured":"Cranshaw IM, Carnaille B. Micrometastases in thyroid cancer. An important finding? Surg Oncol. 2008;17:253\u20138.","journal-title":"Surg Oncol"},{"key":"14742_CR24","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s00268-007-9224-y","volume":"31","author":"Y Ito","year":"2007","unstructured":"Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg. 2007;31:2085\u201391.","journal-title":"World J Surg"},{"key":"14742_CR25","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s00268-013-2345-6","volume":"38","author":"J Lee","year":"2014","unstructured":"Lee J, Song Y, Soh EY. Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence. World J Surg. 2014;38:858\u201362.","journal-title":"World J Surg"},{"key":"14742_CR26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/hed.21600","volume":"33","author":"A Ebrahimi","year":"2011","unstructured":"Ebrahimi A, Clark JR, Zhang WJ, Elliott MS, Gao K, Milross CG, et al. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma. Head Neck. 2011;33:1245\u201351.","journal-title":"Head Neck"},{"key":"14742_CR27","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1002\/cncr.25834","volume":"117","author":"A Ebrahimi","year":"2011","unstructured":"Ebrahimi A, Zhang WJ, Gao K, Clark JR. Nodal yield and survival in oral squamous cancer: defining the standard of care. Cancer. 2011;117:2917\u201325.","journal-title":"Cancer"},{"key":"14742_CR28","first-page":"1461","volume":"36","author":"S-Y Lee","year":"2010","unstructured":"Lee S-Y, Hwang I, Park Y-S, Gardner J, Ro JY. Metastatic lymph node ratio in advanced gastric carcinoma: a better prognostic factor than number of metastatic lymph nodes? Int J Oncol. 2010;36:1461\u20137.","journal-title":"Int J Oncol"},{"key":"14742_CR29","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1245\/s10434-008-0022-z","volume":"15","author":"MD Leggett","year":"2008","unstructured":"Leggett MD, Chen SL, Schneider PD, Martinez SR. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Ann Surg Oncol. 2008;15:2493\u20139.","journal-title":"Ann Surg Oncol"},{"key":"14742_CR30","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1089\/thy.2012.0460","volume":"23","author":"JH Vas Nunes","year":"2013","unstructured":"Vas Nunes JH, Clark JR, Gao K, Chua E, Campbell P, Niles N, et al. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma. Thyroid. 2013;23:811\u20136.","journal-title":"Thyroid"},{"key":"14742_CR31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s40618-018-0969-y","volume":"42","author":"PW Rosario","year":"2019","unstructured":"Rosario PW, Mour\u00e3o G, Calsolari MR. Risk of recurrence in patients with papillary thyroid carcinoma and minimal extrathyroidal extension not treated with radioiodine. J Endocrinol Invest. 2019;42:687\u201392.","journal-title":"J Endocrinol Invest"},{"key":"14742_CR32","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3174\/ajnr.A7484","volume":"43","author":"XQ Xu","year":"2022","unstructured":"Xu XQ, Zhou Y, Su GY, Tao XW, Ge YQ, Si Y, et al. Iodine maps from dual-energy CT to predict extrathyroidal extension and recurrence in papillary thyroid cancer based on a radiomics approach. AJNR Am J Neuroradiol. 2022;43:748\u201355.","journal-title":"AJNR Am J Neuroradiol"},{"key":"14742_CR33","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1089\/thy.2016.0132","volume":"27","author":"LM Youngwirth","year":"2017","unstructured":"Youngwirth LM, Adam MA, Scheri RP, Roman SA, Sosa JA. Extrathyroidal extension is associated with compromised survival in patients with thyroid cancer. Thyroid. 2017;27:626\u201331.","journal-title":"Thyroid"},{"key":"14742_CR34","doi-asserted-by":"publisher","unstructured":"Woo J, Kim H, Kwon H. Impact of multifocality on the recurrence of papillary thyroid carcinoma. J Clin Med. 2021;10(21):5144. Published 2021 Nov 2. https:\/\/doi.org\/10.3390\/jcm10215144.","DOI":"10.3390\/jcm10215144"},{"key":"14742_CR35","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/jamaoto.2021.1976","volume":"147","author":"H Kim","year":"2021","unstructured":"Kim H, Kwon H, Moon BI. Association of multifocality with prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2021;147:847\u201354.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"14742_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijsu.2017.12.035","volume":"50","author":"KR Joseph","year":"2018","unstructured":"Joseph KR, Edirimanne S, Eslick GD. Multifocality as a prognostic factor in thyroid cancer: a meta-analysis. Int J Surg. 2018;50:121\u20135.","journal-title":"Int J Surg"},{"issue":"11","key":"14742_CR37","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1089\/thy.2018.0151","volume":"28","author":"TM Kim","year":"2018","unstructured":"Kim TM, Kim JH, Yoo RE, et al. Persistent\/recurrent differentiated thyroid cancer: clinical and radiological characteristics of persistent disease and clinical recurrence based on computed tomography analysis. Thyroid. 2018;28(11):1490\u20139.","journal-title":"Thyroid"},{"issue":"11","key":"14742_CR38","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1007\/s00268-010-0714-y","volume":"34","author":"Y Erbil","year":"2010","unstructured":"Erbil Y, Sari S, Agcaoglu O, et al. Radio-guided excision of metastatic lymph nodes in thyroid carcinoma: a safe technique for previously operated neck compartments [J]. World J Surg. 2010;34(11):2581\u20138.","journal-title":"World J Surg"},{"issue":"10","key":"14742_CR39","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1089\/thy.2017.0203","volume":"27","author":"SB Chinn","year":"2017","unstructured":"Chinn SB, Zafereo ME, Waguespack SG, et al. Long-term outcomes of lateral neck dissection in patients with recurrent or persistent well-differentiated thyroid cancer. Thyroid. 2017;27(10):1291\u20139.","journal-title":"Thyroid"},{"key":"14742_CR40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1210\/jc.2014-2725","volume":"100","author":"GA Lupoli","year":"2015","unstructured":"Lupoli GA, Okosieme OE, Evans C, Clark PM, Pickett AJ, Premawardhana LDKE, et al. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer. J Clin Endocrinol Metab. 2015;100:100\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"14742_CR41","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/hed.24684","volume":"39","author":"JH Lee","year":"2017","unstructured":"Lee JH, Chung YS, Lee YD. A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study. Head Neck. 2017;39:767\u201371.","journal-title":"Head Neck"},{"key":"14742_CR42","first-page":"52","volume":"4","author":"CS Grant","year":"2015","unstructured":"Grant CS. Recurrence of papillary thyroid cancer after optimized surgery. Gland Surg. 2015;4:52\u201362.","journal-title":"Gland Surg"},{"key":"14742_CR43","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1089\/thy.2018.0128","volume":"29","author":"W Dong","year":"2019","unstructured":"Dong W, Horiuchi K, Tokumitsu H, Sakamoto A, Noguchi E, Ueda Y, et al. Time-varying pattern of mortality and recurrence from papillary thyroid cancer: lessons from a long-term follow-up. Thyroid. 2019;29:802\u20138.","journal-title":"Thyroid"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14742-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14742-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14742-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:59:23Z","timestamp":1757357963000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14742-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14742"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14742-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"10 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The Ethics Committee of Tianjin Medical University Cancer Hospital approved the study (ethical approval number: bc20240416), the data were anonymized, and the need for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1271"}}